Chemoinformaics analysis of 4-Oxo-.beta.-ionone
| Molecular Weight | 206.285 | nRot | 2 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 9 |
| Exact Molecular Weight | 206.131 | nRing | 1 |
| Solubility: LogS | -2.188 | nHRing | 0 |
| Solubility: LogP | 1.952 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 35.3163 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.651 |
| Synth | 3.187 |
| Natural Product Likeliness | 1.638 |
| NR-PPAR-gamma | 0.947 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.853 |
| Pgp-sub | 0.095 |
| HIA | 0.012 |
| CACO-2 | -4.772 |
| MDCK | 0.0000367 |
| BBB | 0.974 |
| PPB | 0.684362 |
| VDSS | 0.918 |
| FU | 0.332378 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.139 |
| CYP2c19-inh | 0.228 |
| CYP2c19-sub | 0.873 |
| CYP2c9-inh | 0.056 |
| CYP2c9-sub | 0.586 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.756 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.445 |
| CL | 3.617 |
| T12 | 0.856 |
| hERG | 0.015 |
| Ames | 0.485 |
| ROA | 0.627 |
| SkinSen | 0.856 |
| Carcinogencity | 0.865 |
| EI | 0.757 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.052 |
| Antiviral | Yes |
| Prediction | 0.619915 |